Lafayette Clinical Research Group

3920 Saint Francis Way
Lafayette, Indiana 47905

We've found

1 trials

at this facility

Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies

Status: Enrolling, Phase III
Updated: 12/31/1969

from

Lafayette, IN

Use our guide to learn which trials are right for you!